FDA grants Priority Review status for TLX250-CDx for kidney cancer PET/CT scans
The Food and Drug Administration (FDA) in America has accepted [...]
Kidney cancer research highlights from ASCO GU 2025
Every year, researchers from around the world gather at a [...]
Spotting symptoms early: the importance of early diagnosis
Cancer Research UK have been highlighting the importance of screening [...]
Cancer Research UK – 74,000 cancer patients not treated on time in 2024
A new analysis by Cancer Research UK revealed that in [...]
New personalised cancer vaccine shows promise for advanced kidney cancer
A new personalised cancer vaccine has shown promising anti-tumour immunity [...]
Belzutifan approved in Europe for advanced kidney cancer and VHL disease
The European Medicines Agency’s (EMA’s) Committee for Medicinal Products for [...]
Belzutifan plus cabozantinib combination shows promise in advanced kidney cancer
Updated results from the phase 2 LITESPARK-003 trial with belzutifan [...]
Promising new combination therapy for advanced kidney cancer
Combinations of tyrosine kinase inhibitors plus immunotherapy have improved treatment [...]
NHS England’s Elective Care Reform Plan
On 6 January 2025, NHS England launched their plan to [...]
FDA approves injectable form of nivolumab
Just after Christmas, the US Food and Drug Administration (FDA) [...]
